Literature DB >> 35218601

Getting the Most out of Consent: Patient-Centered Consent for an Acute Stroke Trial.

Neal W Dickert1, Kathleen Metz2, S Iris Deeds3, Michael J Linke4, Andrea R Mitchell5, Candace D Speight6, Opeolu M Adeoye7.   

Abstract

Informed consent for clinical trials in acute stroke is characterized by challenges related to urgency, cognitive impairment, and geographical separation. Context-appropriate approaches are needed for this setting. We conducted a mixed-methods project involving focus groups and interviews as well as collaboration with a patient advisory panel and a central institutional review board (CIRB) to design and implement a patient-driven consent process for a multicenter trial incorporating adaptive randomization. Remote consent was recognized as challenging but acceptable. Adaptive randomization was viewed positively, but significant potential for misunderstanding was appreciated. Collaboration between the patient advisory panel and the CIRB resulted in a shortened, more patient-centered consent form that was approved at all sites with few modifications. An information sheet was developed as a resource for patients and surrogates after enrollment. Collaboration between investigators, patient partners, and a CIRB can facilitate innovation and implementation of patient-centered, context-appropriate consent strategies.
© 2022 by The Hastings Center. All rights reserved.

Entities:  

Keywords:  human subjects research; informed consent; institutional review board (IRB); patient advisory panel; patient-centered consent process; stroke; stroke clinical trials; surrogate consent

Mesh:

Year:  2022        PMID: 35218601     DOI: 10.1002/eahr.500122

Source DB:  PubMed          Journal:  Ethics Hum Res        ISSN: 2578-2355


  1 in total

1.  Risk Factors of Recurrent Stroke in Young and Middle-Aged Stroke Patients after Interventional Therapy.

Authors:  Xin Dai; Fang Wang; Haiyang Lv; Xiuling Cheng
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.